These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 13727548)

  • 21. [Bacteriostatic concentration of tubazid in experimental tuberculosis].
    Butkina TK
    Probl Tuberk; 1969; 47(5):77-80. PubMed ID: 5367975
    [No Abstract]   [Full Text] [Related]  

  • 22. Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations.
    Gumbo T; Louie A; Liu W; Brown D; Ambrose PG; Bhavnani SM; Drusano GL
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2329-36. PubMed ID: 17438043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of pathological processes after intranasal and subcutaneous infection of guinea pigs. II. Isonicotinic acid hydrazide (INH) resistant strains of Mycobacterium tuberculosis].
    PRZEWORSKA-KANIEWICZ D
    Gruzlica (1926); 1960 Dec; 28():949-54. PubMed ID: 13738336
    [No Abstract]   [Full Text] [Related]  

  • 24. [Animal experimental studies on an intermittent chemotherapy and prevention of tuberculosis. Part 9. Studies on guinea pigs in prevention of a minimal infection with continuous and intermittent doses of isoniazid].
    BARTMANN K; VILLNOW J; SCHWARZ C
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1959; 121():460-5. PubMed ID: 13797266
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis.
    Fattorini L; Gennaro R; Zanetti M; Tan D; Brunori L; Giannoni F; Pardini M; Orefici G
    Peptides; 2004 Jul; 25(7):1075-7. PubMed ID: 15245864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Observations on the use of sulfisoxazole (gantrisin) in 1000 consecutive patients, with particular reference to the frequency of undesirable side effects.
    YOW EM
    Am Pract Dig Treat; 1953 Aug; 4(8):521-5. PubMed ID: 13080563
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical study of a new sulfonamide preparation: Gantrisin by Roche: 3,4-Dimethyl-5-sulfanilamido-isoxazol].
    LANGEMANN H
    Schweiz Med Wochenschr; 1950 Jan; 80(4):78-81. PubMed ID: 15404422
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of early isoniazid treatment in experimental guinea pig tuberculosis.
    PEIZER LR; CHAVES AD; WIDELOCK D
    Am Rev Tuberc; 1957 Nov; 76(5):732-51. PubMed ID: 13478831
    [No Abstract]   [Full Text] [Related]  

  • 30. [A new sulfonamide: gantrisin].
    AUBERTIN E
    J Med Bord; 1950 Dec; 127(12):829-30. PubMed ID: 14803901
    [No Abstract]   [Full Text] [Related]  

  • 31. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.
    Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL
    J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The course of experimental tuberculosis in guinea pigs nursed by mothers treated with isonicotinic acid hydrazide].
    MORICHI G
    Arch Ital Sci Farmacol; 1956 Jul; 6(3):246-8. PubMed ID: 13382476
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental reinfection in arrested guinea pig tuberculosis and its behavior under isoniazid therapy.
    BASTARRACHEA F; GONZALEZ-MENDOZA A; PEREZ-TAMAYO R; BOJALIL LF
    Am Rev Tuberc; 1959 Feb; 79(2):246-50. PubMed ID: 13627429
    [No Abstract]   [Full Text] [Related]  

  • 34. Correlation between isoniazid resistance and superoxide reactivity in mycobacterium tuberculosis KatG.
    Ghiladi RA; Medzihradszky KF; Rusnak FM; Ortiz de Montellano PR
    J Am Chem Soc; 2005 Sep; 127(38):13428-42. PubMed ID: 16173777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pattern of resistance development of Mycobacterium tuberculosis to sulfisoxazole].
    TSUKAMURA M
    Kekkaku; 1960 May; 35():328-30. PubMed ID: 13839681
    [No Abstract]   [Full Text] [Related]  

  • 36. Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis.
    Karakousis PC; Williams EP; Bishai WR
    J Antimicrob Chemother; 2008 Feb; 61(2):323-31. PubMed ID: 18156607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation and pharmacological study of a new sulfonamide; gantrisin].
    MALAGAMBA G; VERDIANI G
    Quad Clin Ostet Ginecol; 1952 Nov; 7(11):709-14. PubMed ID: 13047551
    [No Abstract]   [Full Text] [Related]  

  • 38. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid.
    Vilchèze C; Wang F; Arai M; Hazbón MH; Colangeli R; Kremer L; Weisbrod TR; Alland D; Sacchettini JC; Jacobs WR
    Nat Med; 2006 Sep; 12(9):1027-9. PubMed ID: 16906155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Ni(II)-sulfonamide complexes: synthesis, structural characterization and antibacterial properties. X-ray diffraction of [Ni(sulfisoxazole)2(H2O)4].2H2O and [Ni(sulfapyridine)2].
    Mondelli M; Bruné V; Borthagaray G; Ellena J; Nascimento OR; Leite CQ; Batista AA; Torre MH
    J Inorg Biochem; 2008 Feb; 102(2):285-92. PubMed ID: 17976730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Animal experimental studies on an intermittent chemotherapy and prevention of tuberculosis. VII. Success of continuous and intermittent doses of isoniazid and the triple combination isoniazid, streptomycin, PAS in a therapeutic test in guinea pigs].
    BARTMANN K; VILLNOW J; SCHWARZ C
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1958; 118(5):297-313. PubMed ID: 13596285
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.